Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10018193HBVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20013017HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20021008HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20013016HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20062745HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS44020000HTLV-1ENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TCGA Plot Options
Drug Information
GeneOPRK1
DrugBank IDDB01565
Drug NameDihydromorphine
Target IDBE0000632
UniProt IDP41145
Regulation Typeagonist
PubMed IDs16777416; 19474215; 15178355
CitationsCrooks PA, Kottayil SG, Al-Ghananeem AM, Byrn SR, Butterfield DA: Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine 6-O-sulfate ester congeners. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4291-5. Epub 2006 Jun 13.@@Dietis N, Guerrini R, Calo G, Salvadori S, Rowbotham DJ, Lambert DG: Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. Br J Anaesth. 2009 Jul;103(1):38-49. doi: 10.1093/bja/aep129. Epub 2009 May 27.@@Gilbert AK, Hosztafi S, Mahurter L, Pasternak GW: Pharmacological characterization of dihydromorphine, 6-acetyldihydromorphine and dihydroheroin analgesia and their differentiation from morphine. Eur J Pharmacol. 2004 May 25;492(2-3):123-30.
GroupsExperimental; Illicit
Direct ClassificationMorphinans
SMILES[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC[C@@H]2O
PathwaysDihydromorphine Action Pathway
PharmGKB
ChEMBLCHEMBL1500